NICE has been notified about this procedure and it is part of its work programme. The Interventional Procedures Advisory Committee (IPAC) will consider this procedure and NICE will issue an interventional procedures consultation document about its safety and efficacy for 4 weeks’ public consultation. IPAC will then review the consultation document in the light of comments received and produce a final interventional procedures document, which will be considered by NICE before guidance is issued to the NHS in England, Wales, Scotland and Northern Ireland.
Status In progress
Process IP
ID number 1774
Description Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids is done under general or regional anaesthesia, or sedation. A radiofrequency ablation device with an ultrasound probe at the tip is inserted through the cervix into the endometrial cavity. The ultrasound probe is used to visualise and target the fibroid, which is then ablated with radiofrequency energy. The aim is to shrink the fibroid and reduce symptoms.

Provisional Schedule

Expected publication 31 March 2021

Email enquiries


Key events during the development of the guidance:

Date Update
24 September 2020 - 22 October 2020 Interventional procedure consultation

For further information on how we develop guidance, please see our page about NICE interventional procedures guidance